"Microtechnologies for biological research: From cell culture to drug screening" reviews how microfluidic and microarray-based systems have changed the way we do biology, from early microbioreactors and lab-on-a-chip platforms to today's organ- and tissue-mimetic devices.

This chapter also looks ahead at commercialization, standardization, and the convergence with AI, digital twins and patient-derived organoids.

The potential for translational and personalized medicine is significant, but wider adoption will depend on tackling cost, regulatory approval, interoperability and long-term reliability.

It was a pleasure to collaborate across institutions.

Congratulations! See more.